Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast as anti-pruritic treatment in patients with prurigo nodularis
2016-003018-29Phase 2Completed
- Sponsor
- Herlev & Gentofte Hospital
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apremilast in prurigo nodularis (PN), sponsored by Herlev & Gentofte Hospital. Started Feb 2017; status: completed.
02
Drugs
apremilast
03
Conditions
prurigo nodularis (PN)
Beyond the preview
Go deeper on 2016-003018-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003018-29.